Literature DB >> 30528168

Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.

Marcus J C Long1, Ann P Lawson2, Rick Baggio1, Yu Qian3, Lior Rozhansky2, Domenico Fasci4, Farid El Oualid5, Eranthie Weerapana3, Lizbeth Hedstrom6.   

Abstract

Promiscuous inhibitors of tyrosine protein kinases, proteases and phosphatases are useful reagents for probing regulatory pathways and stabilizing lysates as well as starting points for the design of more selective agents. Ubiquitination regulates many critical cellular processes, and promiscuous inhibitors of deubiquitinases (DUBs) would be similarly valuable. The currently available promiscuous DUB inhibitors are highly reactive electrophilic compounds that can crosslink proteins. Herein we introduce diarylcarbonate esters as a novel class of promiscuous DUB inhibitors that do not have the liabilities associated with the previously reported compounds. Diarylcarbonates stabilize the high molecular weight ubiquitin pools in cells and lysates. They also elicit cellular phenotypes associated with DUB inhibition, demonstrating their utility in ubiquitin discovery. Diarylcarbonates may also be a useful scaffold for the development of specific DUB inhibitors.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Activity profiling; Bcr Abl; Mdm2; USP7; USP9

Mesh:

Substances:

Year:  2018        PMID: 30528168      PMCID: PMC6467287          DOI: 10.1016/j.bmcl.2018.11.055

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  52 in total

1.  Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.

Authors:  N P Dantuma; K Lindsten; R Glas; M Jellne; M G Masucci
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

2.  An isotopically tagged azobenzene-based cleavable linker for quantitative proteomics.

Authors:  Yu Qian; Julianne Martell; Nicholas J Pace; T Eric Ballard; Douglas S Johnson; Eranthie Weerapana
Journal:  Chembiochem       Date:  2013-07-16       Impact factor: 3.164

3.  NADH binds and stabilizes the 26S proteasomes independent of ATP.

Authors:  Peter Tsvetkov; Nadav Myers; Raz Eliav; Yaarit Adamovich; Tzachi Hagai; Julia Adler; Ami Navon; Yosef Shaul
Journal:  J Biol Chem       Date:  2014-03-04       Impact factor: 5.157

4.  Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

Authors:  Gerald Gavory; Colin R O'Dowd; Matthew D Helm; Jakub Flasz; Elias Arkoudis; Anthony Dossang; Caroline Hughes; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Oliver Barker; Hugues Miel; Timothy Harrison
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

5.  Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.

Authors:  J E Mullally; P J Moos; K Edes; F A Fitzpatrick
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

Review 6.  Deubiquitinases in cancer: new functions and therapeutic options.

Authors:  J M Fraile; V Quesada; D Rodríguez; J M P Freije; C López-Otín
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

7.  Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death.

Authors:  J E Mullally; F A Fitzpatrick
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

8.  Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells.

Authors:  Binhua Zhou; Yinglin Zuo; Baojian Li; Hao Wang; Hao Liu; Xianfeng Wang; Xu Qiu; Yun Hu; Shijun Wen; Jun Du; Xianzhang Bu
Journal:  Mol Cancer Ther       Date:  2013-05-21       Impact factor: 6.261

9.  From good substrates to good inhibitors: design of inhibitors for serine and thiol proteases.

Authors:  R Baggio; Y Q Shi; Y Q Wu
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

Review 10.  Deubiquitylating enzymes and drug discovery: emerging opportunities.

Authors:  Jeanine A Harrigan; Xavier Jacq; Niall M Martin; Stephen P Jackson
Journal:  Nat Rev Drug Discov       Date:  2017-09-29       Impact factor: 84.694

View more
  2 in total

Review 1.  Modulating protein-protein interaction networks in protein homeostasis.

Authors:  Mengqi Zhong; Gregory M Lee; Eline Sijbesma; Christian Ottmann; Michelle R Arkin
Journal:  Curr Opin Chem Biol       Date:  2019-03-23       Impact factor: 8.822

Review 2.  Science's Response to CoVID-19.

Authors:  Marcus J C Long; Yimon Aye
Journal:  ChemMedChem       Date:  2021-06-22       Impact factor: 3.540

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.